Lantheus Holdings, Inc.

Contributing Author

Recent Articles by Lantheus Holdings, Inc.

Jun-26	Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide) LNTH GlobeNewswire
Jun-03	Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference LNTH GlobeNewswire
Jun-02	Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI's Image of the Year LNTH GlobeNewswire
May-27	Lantheus to Present at the William Blair 46th Annual Growth Stock Conference LNTH GlobeNewswire
May-21	Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting LNTH GlobeNewswire
May-19	Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting LNTH GlobeNewswire
May-07	Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update LNTH +5.63% GlobeNewswire
Apr-23	Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time LNTH GlobeNewswire
Mar-17	Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) LNTH GlobeNewswire
Mar-06	Lantheus Announces FDA Approval of PYLARIFY TruVu (piflufolastat F 18) Injection LNTH LNTH +10.27% GlobeNewswire
Mar-02	Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA LNTH GlobeNewswire
Feb-26	Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update LNTH GlobeNewswire
Feb-24	Lantheus to Present at March 2026 Investor Conferences LNTH GlobeNewswire
Feb-12	Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time LNTH GlobeNewswire
Jan-02	Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies LNTH GlobeNewswire
Nov-24	Lantheus to Present Florbetaben F 18 Data at CTAD 2025 LNTH GlobeNewswire
Nov-06	Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update LNTH -6.19% GlobeNewswire
Nov-06	Lantheus Announces Leadership Transition Plan LNTH -6.19% GlobeNewswire
Oct-30	Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) LNTH GlobeNewswire
Oct-28	Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer's Disease LNTH GlobeNewswire
Oct-23	Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time LNTH GlobeNewswire
Sep-24	Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan LNTH GlobeNewswire
Sep-02	Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference LNTH GlobeNewswire
Aug-06	Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update LNTH -28.58% GlobeNewswire
Aug-06	Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent LNTH -28.58% GlobeNewswire
Jul-23	Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time LNTH GlobeNewswire
Jul-22	Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D LNTH GlobeNewswire
Jun-11	Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting LNTH GlobeNewswire
Jun-10	Lantheus to Present at the 2025 Truist Securities MedTech Conference LNTH GlobeNewswire
Jun-03	Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 LNTH GlobeNewswire
May-07	Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update LNTH -23.23% GlobeNewswire
May-06	Lantheus Announces Sale of SPECT Business to SHINE Technologies LNTH GlobeNewswire
Apr-30	Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies LNTH GlobeNewswire

Lantheus Holdings, Inc.

Recent Articles by Lantheus Holdings, Inc.

Upgrade your Finviz experience